Comparison of chemosensitivity between primary site and liver metastasis in CD-DST.

5-FU, 5-fluorouracil; SN38, the active metabolite of irinotecan; OHP, the active metabolite of oxaliplatin.

There was no significant difference in chemosensitivity when comparing the liver metastasis and the primary tumor.

*

statistical significance.

Categories

License

CC BY 4.0